Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08OVG
|
||||
Former ID |
DIB016122
|
||||
Drug Name |
CKD-516
|
||||
Synonyms |
S-516; Tubulin polymerization inhibitor (iv, solid cancer), Chong Kun Dang
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 1 | [523842] | ||
Company |
Chong Kun Dang Pharmaceutical Corp
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H29ClN6O5S
|
||||
Canonical SMILES |
c1(nc(cs1)c1cc(c(C(=O)c2cc(c(c(c2)OC)OC)OC)cc1)n1ncnc1)<br />NC(=O)[C@@H](N)C(C)C.Cl
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Inhibitor | [532537] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.